loading
Schlusskurs vom Vortag:
$3.90
Offen:
$3.91
24-Stunden-Volumen:
341.34K
Relative Volume:
0.62
Marktkapitalisierung:
$212.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-4.5476
EPS:
-0.84
Netto-Cashflow:
$-18.45M
1W Leistung:
+12.87%
1M Leistung:
+144.55%
6M Leistung:
+226.07%
1J Leistung:
+87.01%
1-Tages-Spanne:
Value
$3.81
$4.00
1-Wochen-Bereich:
Value
$3.29
$4.30
52-Wochen-Spanne:
Value
$0.7203
$4.30

Quince Therapeutics Inc Stock (QNCX) Company Profile

Name
Firmenname
Quince Therapeutics Inc
Name
Telefon
415-910-5717
Name
Adresse
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Name
Mitarbeiter
36
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-24
Name
Neueste SEC-Einreichungen
Name
QNCX's Discussions on Twitter

Vergleichen Sie QNCX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
QNCX
Quince Therapeutics Inc
3.81 217.16M 0 -31.39M -18.45M -0.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.88 112.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
699.24 73.91B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
417.70 56.81B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
892.07 55.46B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
193.92 41.92B 447.02M -1.18B -906.14M -6.1812

Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-05 Eingeleitet Citizens JMP Mkt Outperform
2025-03-24 Eingeleitet Oppenheimer Outperform

Quince Therapeutics Inc Aktie (QNCX) Neueste Nachrichten

pulisher
Dec 05, 2025

Trading Action: Is Quince Therapeutics Inc stock a safe buy before earnings2025 Price Momentum & Accurate Trade Setup Notifications - BỘ NỘI VỤ

Dec 05, 2025
pulisher
Dec 02, 2025

Quince Therapeutics, Inc. (QNCX) -11.5% in After-hours: No Clear Catalyst Driving Decline - Stocks Telegraph

Dec 02, 2025
pulisher
Dec 02, 2025

Quince Therapeutics, Inc. (QNCX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Dec 02, 2025
pulisher
Dec 02, 2025

Why Quince Therapeutics Inc. stock is trending among retail traders2025 Performance Recap & Real-Time Buy Signal Alerts - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Why Quince Therapeutics Inc. stock remains resilientWeekly Investment Recap & Weekly Top Stock Performers List - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Quince Therapeutics (QNCX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Dec 01, 2025

Prepare Yourself for Liftoff: Quince Therapeutics Inc (QNCX) - Setenews

Dec 01, 2025
pulisher
Nov 27, 2025

Quince Therapeutics Stock Surges 105%, With A 8-Day Winning Spree - Trefis

Nov 27, 2025
pulisher
Nov 26, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives $8.00 Consensus Target Price from Analysts - Defense World

Nov 26, 2025
pulisher
Nov 26, 2025

Quince Therapeutics, Inc. (QNCX) 18.8% in Intraday Trading: Surge Amid Upcoming Investor Events - Stocks Telegraph

Nov 26, 2025
pulisher
Nov 26, 2025

Quince Therapeutics: Could NEAT Phase 3 Data Deliver The First Therapy For Ataxia-Telangiectasia? - RTTNews

Nov 26, 2025
pulisher
Nov 26, 2025

Quince Therapeutics Stock Rockets 59% With 7-Day Winning Streak - Trefis

Nov 26, 2025
pulisher
Nov 25, 2025

Adversity is less terrifying than hope: Quince Therapeutics Inc (QNCX) - Setenews

Nov 25, 2025
pulisher
Nov 24, 2025

EBITDA per share of Quince Therapeutics, Inc. – NASDAQ:QNCX - TradingView

Nov 24, 2025
pulisher
Nov 24, 2025

Quince Therapeutics to Participate at Investor Events in December 2025 - Markets Financial Content

Nov 24, 2025
pulisher
Nov 21, 2025

Is Quince Therapeutics Inc. stock a dividend growth opportunity2025 Historical Comparison & Growth Oriented Trade Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

A new trading data show Quince Therapeutics Inc (QNCX) is showing positive returns. - Setenews

Nov 20, 2025
pulisher
Nov 20, 2025

Can Quince Therapeutics Inc. stock weather global recessionWeekly Stock Recap & Detailed Earnings Play Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Sentiment analysis tools applied to Quince Therapeutics Inc.Quarterly Portfolio Report & Weekly High Conviction Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How analysts rate Quince Therapeutics Inc. stock todayM&A Rumor & Low Risk Entry Point Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Statistical indicators supporting Quince Therapeutics Inc.’s strengthGDP Growth & Technical Entry and Exit Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Quince Therapeutics Inc. stock double in next 5 yearsMarket Trend Review & Weekly Hot Stock Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Combining machine learning predictions for Quince Therapeutics Inc.Global Markets & Daily Chart Pattern Signal Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Quince Therapeutics Inc. stock a good choice for value investorsMarket Risk Summary & Risk Managed Investment Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How interest rate cuts could boost Quince Therapeutics Inc. stockShort Setup & Daily Oversold Stock Bounce Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What indicators show strength in Quince Therapeutics Inc.July 2025 Levels & Weekly High Return Opportunities - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Quince Therapeutics Inc. stock oversold or undervaluedJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

Quince Therapeutics Reports Q3 2025 Financial Results - MSN

Nov 17, 2025
pulisher
Nov 16, 2025

Is Quince Therapeutics Inc. stock ready for a breakout2025 Macro Impact & Daily Volume Surge Signals - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Is Quince Therapeutics Inc. stock positioned for digital transformationEarnings Summary Report & AI Forecast Swing Trade Picks - newser.com

Nov 15, 2025

Finanzdaten der Quince Therapeutics Inc-Aktie (QNCX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.19
price down icon 1.15%
$95.83
price down icon 0.92%
$31.15
price down icon 2.33%
$96.74
price down icon 0.54%
biotechnology ONC
$321.94
price down icon 1.20%
$193.73
price down icon 1.33%
Kapitalisierung:     |  Volumen (24h):